Regedent

What Regedent does

Regedent is a privately held Swiss medical device company headquartered in Zurich that develops, manufactures, and distributes a portfolio of dental regeneration products built around cross-linked hyaluronic acid (xHyA) technology. The company addresses hard and soft tissue regeneration in periodontology, guided bone regeneration, and peri-implantitis treatment, with a product portfolio comprising hyaDENT BG (a tissue regenerator), PERISOLV (a sodium-hypochlorite/amino-acid biofilm eraser), SMARTBRANE (a resorbable membrane for guided bone regeneration), SMARTGRAFT (a bone substitute), and the combined CLEAN&SEAL protocol that pairs PERISOLV with hyaDENT BG to enable non-surgical periodontal regeneration. The underlying technology — naturally cross-linked hyaluronic acid gel — is supported by more than ten years of preclinical and clinical evidence, including histological confirmation of new cementum, periodontal ligament, and bone formation.

The company sells primarily to periodontists, oral surgeons, maxillofacial surgeons, and general dentists performing regenerative dental procedures, as well as to the dental practices and clinics in which they operate. Demand generation is event-driven: Regedent invests heavily in scientific congress participation (EAO, EuroPerio, International Osteology Symposium), master courses (e.g., the Sculean Master Course in Periodontology), symposia, webinars, and a clinical expert network anchored by key opinion leaders such as Prof. Anton Sculean and Prof. Daniel Buser. Pricing is quote-based and not publicly disclosed, consistent with specialty medical-device sales rather than consumer-grade commerce.

Regedent generates revenue through the sale of its proprietary devices and biomaterials via three go-to-market layers: a network of authorized local distributors covering more than 30 countries, wholly-owned regional subsidiaries — REGEDENT GmbH in Germany (Dettelbach) and Regedent Italia Srl in Italy (Sandrigo) — which also operate the company's own e-commerce storefront at shop.regedent.com, and a French office supporting direct sales. The legal entity REGEDENT AG is incorporated in Zurich under Swiss law, with no evidence of external institutional investment or public listing disclosed in the available sources.

Name

Regedent

Legal name

REGEDENT AG

Website

https://regedent.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Regedent is a Swiss medical device company that develops and distributes cross-linked hyaluronic acid-based dental regeneration products — gels, biofilm erasers, resorbable membranes, and bone grafts — to periodontists and dental clinics across more than 30 countries.

Ownership category

akta.pro rank

Product category

Dental Regeneration Devices

NAICS

Dental Equipment and Supplies Manufacturing (339114), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Dental Equipment & Supplies (3843), Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Periodontal Regeneration (GTR/EMD/Biologics) (HLABACAI)

akta.pro secondary industries

Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics) (HLAHAEAE), Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

Keywords

• Dental regeneration devices
• Hyaluronic acid biomaterials
• Periodontal therapy products
• Bone graft substitutes
• Dental medical devices

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Medical Device and Biomaterial Sales: Regedent generates revenue through the sale of proprietary dental regeneration products including cross-linked hyaluronic acid gels, biofilm erasers, resorbable membranes, and bone graft substitutes to dental professionals and practices worldwide through distributors.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Regedent manufactures and sells a portfolio of dental regeneration medical devices based on cross-linked hyaluronic acid technology for periodontology, bone augmentation, and peri-implantitis treatment. The offering comprises hyaDENT BG (tissue regenerator), PERISOLV (biofilm eraser), SMARTBRANE (resorbable membrane), SMARTGRAFT (bone substitute), and the CLEAN&SEAL combined therapy system. These products are sold to dental professionals and clinics through distributors in over 30 countries and via an online shop.

Product overview

Regedent is a dental regeneration company offering a portfolio of hyaluronic acid-based medical devices and regenerative solutions for periodontology, bone augmentation, and peri-implantitis treatment. The product portfolio centers on cross-linked hyaluronic acid technology, comprising: hyaDENT BG (a tissue regenerator), combined with the CLEAN&SEAL concept (which pairs PERISOLV biofilm eraser with hyaDENT BG), SMARTBRANE resorbable membranes for guided bone regeneration, and SMARTGRAFT bone substitute materials. These products work together as an integrated regeneration system designed to accelerate dental tissue healing through minimally invasive, user-friendly, and affordable solutions.

Differentiator

Problem solved

Functional benefit

Brands

• CLEAN&SEAL: Periodontal and periimplant therapy product combining sodium hypochlorite and amino acids for biofilm removal.
• hyaDENT BG
• PERISOLV
• SMARTBRANE
• SMARTGRAFT

Products and services

• hyaDENT BG A naturally cross-linked hyaluronic acid tissue regenerator used for periodontal and bone regeneration in the treatment of periodontitis and peri-implantitis, promoting formation of new cementum, periodontal ligament, and bone.
• PERISOLV A biofilm eraser gel containing sodium hypochlorite and amino acids designed to facilitate cleaning and removal of bacterial biofilm from periodontal pockets.
• SMARTBRANE A resorbable membrane used in guided bone regeneration (GBR) procedures to support and protect the healing tissue.
• SMARTGRAFT A bone graft and bone substitute material used for hard tissue regeneration and bone augmentation procedures.
• CLEAN&SEAL A periodontal and peri-implant therapy system combining PERISOLV (sodium hypochlorite and amino-acid gel for biofilm removal) with hyaDENT BG (cross-linked hyaluronic acid for tissue regeneration) to achieve periodontal regeneration through non-surgical therapy.

Quantifiable outcome

• Significant clinical improvements in probing depth reduction and clinical attachment gain compared to conventional methods
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Thommen Medical ItaliaminorChannel Partner/ Reseller/ DistributorPartnership between Regedent Italia and Thommen Medical Italia for distribution of dental regeneration products in Italy.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Geistlich Pharma: Swiss-headquartered leader in dental bone regeneration (Bio-Oss, Bio-Gide) — directly comparable to Regedent's SMARTGRAFT and SMARTBRANE hard-tissue regeneration offerings and overlapping end customers in periodontology and implantology.
• ACE Surgical Supply: US-based manufacturer of dental bone grafting materials, membranes, and regenerative supplies — directly comparable to Regedent's SMARTGRAFT and SMARTBRANE offerings.
• botiss biomaterials: Berlin-based dental regeneration specialist offering bone substitutes, membranes, and soft-tissue products — closely comparable to Regedent's regenerative portfolio and periodontist/implantologist customer base.

Broad incumbents

• ZimVie (now part of Global Dental Science): Spun-off dental and spine business offering regenerative biomaterials, membranes, and bone grafts that overlap with Regedent's hard-tissue regeneration portfolio.
• Dentsply Sirona: Largest diversified dental equipment and consumables manufacturer; its regenerative and implant-adjacent offerings make it an indirect competitor with far greater commercial scale and distribution depth.
• Envista Holdings (Nobel Biocare, Implant Direct): Dental implant and consumables conglomerate whose regenerative and implant-adjacent offerings compete in the same peri-implantitis and bone augmentation procedures Regedent targets.
• Straumann Group: Global dental implant leader (also parent of Geistlich) with broad regeneration, implant, and digital dentistry portfolios — competes with Regedent across peri-implantitis and GBR procedures, especially via bundled solutions.

Emerging players

• Collagen Solutions: Supplier of medical-grade collagen and biological materials used in dental and orthopedic regeneration — overlapping technology class with Regedent's biologic regeneration portfolio.
• BEGO: German dental prosthetics and implant company with selective regenerative offerings; comparable to Regedent in serving specialist dental workflows in the DACH region.

Regional players

• MIS Implants Technologies: Israeli-origin dental implant company with growing regenerative biomaterials presence; competes with Regedent in implantology-driven GBR and peri-implant workflows, mainly outside DACH.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/regedent
• LinkedInlinkedin.com/company/regedent-ag

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regedent